期刊文献+

检测冠心病患者α_1-酸性糖蛋白和C-反应蛋白的意义 被引量:3

α_1-acid glycoprotein and C-reactive proteinin patients with coronary heart disease
下载PDF
导出
摘要 目的 探讨不同类型冠心病(CHD)患者α1 酸性糖蛋白(AAG)和C 反应蛋白(CRP)的变化及其临床意义。方法 选择28例急性心肌梗死患者(AMI组),35 例不稳定型心绞痛患者(UAP组),30 例稳定型心绞痛患者(SAP组),30例非冠心病患者(对照组),分别测定其血浆 AAG 和 CRP 水平。所有患者均行冠状动脉造影,按Gensini积分法评定其冠状动脉狭窄程度,对结果进行统计学分析。结果 ①AMI组血浆 AAG、CRP水平高于 UAP组、SAP组和对照组(P<0.001); UAP组血浆 AAG、CRP 水平高于 SAP 组和对照组(P < 0.001); SAP 组血浆AAG、CRP水平稍高于对照组,但差异无统计学意义(P>0.05)。②随着冠状动脉狭窄程度加重,即 Gensini积分的增加,AAG、CRP水平升高越明显(P<0.001)。③冠状动脉3 支病变和双支病变组血浆 AAG、CRP水平高于单支病变组(P<0.005)。结论 血浆AAG和CRP水平可作为识别 CHD高危患者、监测病情变化的指标,其升高程度与冠状动脉粥样硬化程度有明显相关性。 Objective To observe the change and the clinical significance of plasma α 1-acid glycoprotein(AAG) and C-reactive protein(CRP) levels in different types of coronary heart disease(CHD). Methods AAG and CRP were measured in 28 cases of acute myocardial infarction(AMI), 35 unstable angina pectoris (UAP) , 30 stable angina pectoris(SAP) and 30 controls. Coronary angiography was performed in all the patients,and the severity of coronary stenosis was evaluated by the Gensini score. Results ①AAG and CRP levels were higher in AMI group than those in UAP group, SAP group and controls(P< 0.001); The levels of AAG and CRP in UAP group were higher than those in SAP group and controls(P< 0.001); There is no difference between the latter two groups(P> 0.05).② AAG and CRP levels were significantly correlated with severity of coronary stenosis(Gensini Score)(P< 0.001). ③AAG and CRP levels in three branches' and double branches' groups were higher than those of single branch group(P< 0.005).Conclusion AAG and CRP levels might be used to identify high-risk patients with CHD and to monitor the change of the disease , and they are related with severity of coronary atherosclerosis.
出处 《临床荟萃》 CAS 北大核心 2005年第7期374-376,共3页 Clinical Focus
关键词 冠状动脉疾病 Α1-酸性糖蛋白 C-反应蛋白 coronary disease α1-acid glycoprotein C-reactive protein
  • 相关文献

参考文献11

  • 1杨胜利,何秉贤,何作云,张华,何学兰,张伟.急性冠脉综合征患者血清C-反应蛋白浓度的变化及意义[J].中国急救医学,2003,23(3):135-138. 被引量:49
  • 2LIBBY P, RIDKER P M. Novel inflammatory markers of coronary risk: theory versus practice[J]. Circulation 1999;100(11) : 1148-1150.
  • 3MUELLER C, BUETTNER H J, HODGSON J M, et al.Inflammatory and long-term mortality after non-ST-elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients[J]. Circulation, 2002,105(12):1412-1415.
  • 4CHEW D P, BHATT D L,ROBBINS M A, a al. Incremental prognostic value of elevated baseline C-reactive protein amongestablished markers of risk in percutaneous coronary intervention[J].Circulation,2001,104(9):992-997.
  • 5MORI T, SASAKI J, KAWAGUCHI H, et al. Serum glycoproteins and severity of coronary atherosclerosis[J]. Am Heart J,1995,129(2) :234-237.
  • 6TORZEWSKI M, RIST C, MORTENSEN R F, et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis[J].Arterioscler Thromb Vasc Biol 2000, 20(9) :2094-2099.
  • 7PASCERI V, WILLERSON J T, YEH E T. Direct proinflammatory effect of C-reactive protein on human endothelial cells[J]. Circulation 2000, 102(18):2165-2168.
  • 8PASCERI V, CHANG J, WILLERSON J T, et al.Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs[J]. Circulation 2001, 103 (21)2531-2534.
  • 9ZWAKA T P, HOMBACH V, TORZEWSKI J. C-reactive protein mediated by low density lipoprotein uptake by macrophages: implications for atherosclerosis[J]. Circulation 2001, 103(9)11194-1197.
  • 10TORZEWSKI J, TORZEWSKI M, BOWYER D E, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosc leroticlesions of human coronary arteries[J]. Arterioscler Thromb Vasc Biol 1998. 18(9),1386-1392.

共引文献48

同被引文献47

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部